NYSE:CANF | Income Statement | Can-Fite BioPharma Ltd.

Complete source-backed income-statement history.

Available history
2016-12-31 to 2025-12-31
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$405,000.00$6.69M$10.36M-$9.95M$122,000.00-$9.83M-$9.83M-$5.97-$5.971,646,2081,646,208
2024-12-31$674,000.00$5.76M$8.8M-$8.13M$250,000.00-$7.88M-$7.88M-$10.86-$10.86725,309725,309
2023-12-31$743,000.00$5.98M$8.94M-$8.2M$561,000.00-$7.63M-$7.63M-$17.92-$17.92426,111426,111
2022-12-31$810,000.00$7.76M$263,000.00$10.91M-$10.1M-$77,000.00-$10.17M-$10.17M-$0.01-$0.01815,746,293815,746,293
2021-12-31$853,000.00$9.85M$466,000.00-$12.84M$227,000.00-$12.62M-$12.62M-$0.03-$0.03553,079,638553,079,638
2020-12-31$763,000.00$11.95M$317,000.00-$14.14M-$304,000.00-$14.44M-$14.44M-$0.04-$0.04358,411,297358,411,297
2019-12-31$2.03M$10.98M-$12.01M-$618,000.00-$12.63M-$12.63M85,909,859
2018-12-31$3.82M$6.08M-$5.41M-$1.15M-$6.57M-$6.57M38,902,214
2017-12-31$5.11M
2016-12-31$6.12M